Vaccine News and Research

Latest Vaccine News and Research

COVID-19 vaccination lowers risk of developing severe cardiovascular conditions

People who have been fully vaccinated against COVID-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to COVID-19 infection, according to a nationwide study at the University of Gothenburg.

30 Sep 2024

The World Vaccine Congress returns to Barcelona, Spain

The World Vaccine Congress in Barcelona unites experts to discuss vaccine innovation, sustainability, and global preparedness in the evolving biotech landscape.

From World Vaccine Congress Europe 30 Sep 2024

WHO announces recommended viral composition for 2025 influenza vaccines

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2025 influenza season in the southern hemisphere.

27 Sep 2024

Global leaders unite to tackle drug-resistant bacteria

World leaders meeting in New York have backed a new set of goals and pledged to find US$100 million in funding to address the problem of drug-resistant bacteria, a global crisis that is all the more acute in the poorest countries.

27 Sep 2024

Study shows gradual waning of MMR vaccine effectiveness over time

The MMR vaccine remains the best protection against measles, according to a modelling study in England which suggests the level of protection decreases slightly over time.

27 Sep 2024

Study: MMR vaccine remains the most effective measure to prevent measles infection

Most measles cases in England are among unvaccinated individuals. But, between 2011 and 2019, the proportion of measles cases in adults who received two doses of the MMR vaccine in England increased from 1.9% (20/1064) to 7.2% (57/790), however the cause of this increase remains unclear.

26 Sep 2024

Antiviral drug molnupiravir linked to new mutations in SARS-CoV-2

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown.

26 Sep 2024

Unmedicated mental health conditions linked to lower COVID-19 vaccination rates

Vaccination coverage for COVID-19 is high in both people with and without mental illness, according to a large multinational study led by researchers at Karolinska Institutet and published in Nature Communications.

26 Sep 2024

COVID-19 causes lasting cognitive impairment tied to brain injury markers

Researchers found that COVID-19 patients experienced widespread cognitive deficits one year post-hospitalization, associated with elevated brain injury markers and reduced brain volume. Cognitive recovery plateaued over time, suggesting lasting impacts.

26 Sep 2024

H5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?

Researchers reveal how H5N1 viruses rapidly adapted to mammals through genetic reassortment and specific mutations, raising concerns over potential pandemic risks. Evidence from mink, marine mammals, and dairy cattle shows mammal-to-mammal transmission.

25 Sep 2024

Optimized nanoadjuvants enhance in situ tumor vaccine for ovarian cancer

This new article publication from Acta Pharmaceutica Sinica B, discusses how molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH.

25 Sep 2024

Researchers uncover key to combat Campylobacter infections

Bacterial infections resulting in enteritis, sometimes extra-intestinal infections such as sepsis, continue to be a global health concern.

25 Sep 2024

COVID-19 pandemic reduced sexual partners and activity in the U.S.

The COVID-19 pandemic significantly reduced the number of sexual partners and sexual encounters in the U.S., with non-married women experiencing the most pronounced declines.

24 Sep 2024

Review highlights failures in global control strategies for bird flu transmission

A review of sustained mammal-to-mammal bird flu transmission in diverse species, led by The Pirbright Institute, shows global control strategies are not working.

24 Sep 2024

New Health Impact Investment Platform launches to strengthen primary care

Execution is starting under the new Health Impact Investment Platform on the first country health investment plans turning original commitment into operational reality.

24 Sep 2024

Nearly half of people older adults plan to get the updated COVID-19 vaccine, poll suggests

The newly updated COVID-19 vaccine just arrived in pharmacies and clinics nationwide, and a new poll suggests nearly half of people age 50 and older plan to get it.

23 Sep 2024

Florida’s new covid booster guidance is straight-up misinformation

In what has become a pattern of spreading vaccine misinformation, the Florida health department is telling older Floridians and others at highest risk from covid-19 to avoid most booster shots, saying they are potentially dangerous.

23 Sep 2024

New two-dose HIV vaccine strategy shows promise for stronger immune response

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.

20 Sep 2024

Study shows video games can alleviate PTSD flashbacks

A single treatment session, which includes the video game Tetris, can reduce symptoms of post-traumatic stress disorder (PTSD).

20 Sep 2024

Lonza nominates Juan Andres and Eric Drapé as independent Board Members

Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at the Lonza Group Annual General Meeting (AGM) in May 2025.

From Lonza 20 Sep 2024